Evidence map›Paper›PMID 26755608›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.

Nanhong Lou, Takahiro Takano, Yong Pei, Anna L Xavier, Steven A Goldman, Maiken Nedergaard

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 382 citations in OpenAlex.

  1. SLC25A4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Immune-mediated excitotoxicity in brain disorders.Nature reviews. Immunology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Roles of Glia in Synapse Nano-organization.Advances in neurobiology · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Nanhong LouCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642;
Takahiro TakanoCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642;
Yong PeiCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642;
Anna L XavierCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642;
Steven A GoldmanCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
Maiken NedergaardCenter for Translational Neuromedicine, University of Rochester Medical School, Rochester, NY 14642; Center for Translational Neuromedicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark nedergaard@urmc.rochester.edu.
University of Rochester Medical Center · USUniversity of Copenhagen · DK

Funding

A Humanized Mouse Model of Astrocytic Pathology in SchizophreniaR01MH099578 · NIMH · UNIVERSITY OF ROCHESTER · PI GOLDMAN, STEVEN ALAN, NEDERGAARD, MAIKEN · 2013 to 2017
$2.8M
An iPSC based humanized mouse model of dysmyelination in schizophreniaR01MH104701 · NIMH · UNIVERSITY OF ROCHESTER · PI GOLDMAN, STEVEN ALAN · 2014 to 2018
$2.1M
Hemichannels, Astrocytic Release, and Neuropathic PainR01DE022743 · NIDCR · DUKE UNIVERSITY · PI JI, RU-RONG, NEDERGAARD, MAIKEN · 2012 to 2016
$2.0M
Failure of metabolite clearance in a model of multi-lacunar infarctsR01NS078167 · NINDS · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN · 2012 to 2016
$1.8M
The glymphatic system, a new concept in glia biologyR01NS078304 · NINDS · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN · 2012 to 2016
$1.7M
Molecular Regulation of Human Glial Progenitor Cell-Based RemyelinationR01NS075345 · NINDS · UNIVERSITY OF ROCHESTER · PI GOLDMAN, STEVEN ALAN · 2011 to 2015
$1.7M
ATP as the instigator of inflammatory responses to spinal cord injuryR01NS075177 · NINDS · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN · 2012 to 2016
$1.6M
Glymphatic function in a transgenic rat model of Alzheimer's diseaseR01AG048769 · NIA · UNIVERSITY OF ROCHESTER · PI BENVENISTE, HELENE D, NEDERGAARD, MAIKEN · 2014 to 2018
$1.4M
Analgesic actions of adenosine A1 receptor along axonal tracts in chronic painR01AT007945 · NCCIH · UNIVERSITY OF ROCHESTER · PI TAKANO, TAKAHIRO · 2013 to 2017
$1.4M
NCCIH NIH HHS R01 AT007945NCCIH NIH HHS R01AT007945NIA NIH HHS R01 AG048769NIDCR NIH HHS R01 DE022743NIDCR NIH HHS R01DE022743NIMH NIH HHS R01 MH099578NIMH NIH HHS R01 MH104701NINDS NIH HHS R01 NS075177NINDS NIH HHS R01NS075177NINDS NIH HHS R01 NS075345NINDS NIH HHS R01 NS078167NINDS NIH HHS R01 NS078304
6 · The paper itself

Abstract

Microglia are integral functional elements of the central nervous system, but the contribution of these cells to the structural integrity of the neurovascular unit has not hitherto been assessed. We show here that following blood-brain barrier (BBB) breakdown, P2RY12 (purinergic receptor P2Y, G-protein coupled, 12)-mediated chemotaxis of microglia processes is required for the rapid closure of the BBB. Mice treated with the P2RY12 inhibitor clopidogrel, as well as those in which P2RY12 was genetically ablated, exhibited significantly diminished movement of juxtavascular microglial processes and failed to close laser-induced openings of the BBB. Thus, microglial cells play a previously unrecognized protective role in the maintenance of BBB integrity following cerebrovascular damage. Because clopidogrel antagonizes the platelet P2Y12 receptor, it is widely prescribed for patients with coronary artery and cerebrovascular disease. As such, these observations suggest the need for caution in the postincident continuation of P2RY12-targeted platelet inhibition.

Indexed as

Blood-Brain BarrierAnimalsCell MovementClopidogrelMaleMiceMice, Inbred C57BLMicrogliaPlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12TiclopidineClopidogrelP2ry12 protein, mousePlatelet Aggregation InhibitorsReceptors, Purinergic P2Y12Ticlopidineblood–brain barrierclopidogrelmicrogliapurinergic receptorsstroke

Identifiers

PMID26755608
PMCPMC4743790
OpenAlexW2234493563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.